TEFAF SUPPORTS CANCER RESEARCH

Cancer is the most common cause of death in the world today. One out of three people is diagnosed with cancer at some point in their lives, and fifty percent of those diagnosed will die of the disease, despite such treatments as radiation therapy, chemotherapy and surgery. In the next ten years, the number of diagnoses of cancer will greatly increase, but the tide can be reversed by scientific cooperation on an international scale. Funding is crucial in ensuring that researchers can continue their work to beat cancer, and since 2006 TEFAF has supported research and international collaboration by means of a special Chair of Oncology at the research institute GROW, the School for Oncology and Developmental Biology at the Maastricht University Medical Centre.

A STRONG IMPULSE TO ACHIEVE INTERNATIONAL COOPERATIONS

Professor and Chairwoman Lisa Coussens, cancer biologist at the Department of Cell Development & Cancer Biology, and Associate Director of Basic Research in the Knight Cancer Institute, at Oregon Health & Sciences University (OHSU), Portland (US) has been appointed as Visiting Professor for the Chair of Oncology in 2019.

Professor Coussens specializes in understanding the role of immune cells and their mediators as critical regulators of cancer development, and identification of immune targets for anti-cancer immunotherapy. She has published many important studies and has received a number of prestigious scientific awards recognizing her laboratories contributions to the field of tumor immunology.

THE FUTURE OF CANCER MANAGEMENT

In the next ten years, the number of cancer diagnoses will increase. At the same time, novel cancer diagnostics and therapeutics will be developed. The coming decades will show an increased understanding of cancer biology and a plethora of innovations in cancer prevention and management. In order to translate these developments efficiently to the cancer patient, scientific collaboration at an international scale is warranted.

Since 2006, the European Fine Art Fair (TEFAF) is supporting international collaboration in cancer research by funding a special Chair of Oncology for visiting professors at GROW, the School for Oncology and Developmental Biology at Maastricht UMC+.

FURTHER FUNDING IS NECESSARY IN THE BATTLE AGAINST CANCER

The Cancer Research Fund Limburg collects money for cancer research at the Maastricht University Medical Centre. Research into preventing and curing cancer is much needed, but it is only through international collaboration between researchers that the battle against cancer can be won. The aim of the Cancer research fund is to decrease the incidence of cancer and increase the number of people who recover from this disease by raising funds, specifically The Cancer Research Fund founded by Health Foundation Limburg (HFL), Maastricht University Medical Centre + (Maastricht UMC +) and the Dutch Wilhelmina Foundation / Cancer Research Foundation (KWF). The foundation has a passionate ambassador in internationally renowned violinist Andre Rieu, who was born in Maastricht.

For further information visit Kankeronderzoeksfonds or you can donate directly to NL06INGB0005043912.